Free Trial

Medtronic (MDT) Competitors

Medtronic logo
$89.63 +0.10 (+0.11%)
Closing price 03:59 PM Eastern
Extended Trading
$90.03 +0.40 (+0.44%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MDT vs. DXCM, ISRG, ABT, JNJ, NVST, SYK, TMO, BSX, BDX, and EW

Should you be buying Medtronic stock or one of its competitors? The main competitors of Medtronic include DexCom (DXCM), Intuitive Surgical (ISRG), Abbott Laboratories (ABT), Johnson & Johnson (JNJ), Envista (NVST), Stryker (SYK), Thermo Fisher Scientific (TMO), Boston Scientific (BSX), Becton, Dickinson and Company (BDX), and Edwards Lifesciences (EW). These companies are all part of the "medical" sector.

Medtronic vs. Its Competitors

Medtronic (NYSE:MDT) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership.

Medtronic has higher revenue and earnings than DexCom. Medtronic is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medtronic$33.54B3.43$4.66B$3.6224.76
DexCom$4.03B8.16$576.20M$1.3462.60

Medtronic has a beta of 0.8, suggesting that its share price is 20% less volatile than the S&P 500. Comparatively, DexCom has a beta of 1.44, suggesting that its share price is 44% more volatile than the S&P 500.

In the previous week, Medtronic had 37 more articles in the media than DexCom. MarketBeat recorded 54 mentions for Medtronic and 17 mentions for DexCom. DexCom's average media sentiment score of 1.36 beat Medtronic's score of 1.20 indicating that DexCom is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Medtronic
46 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
DexCom
12 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

82.1% of Medtronic shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 0.2% of Medtronic shares are owned by company insiders. Comparatively, 0.3% of DexCom shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Medtronic currently has a consensus target price of $98.19, indicating a potential upside of 9.55%. DexCom has a consensus target price of $99.60, indicating a potential upside of 18.73%. Given DexCom's stronger consensus rating and higher possible upside, analysts clearly believe DexCom is more favorable than Medtronic.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medtronic
0 Sell rating(s)
11 Hold rating(s)
9 Buy rating(s)
2 Strong Buy rating(s)
2.59
DexCom
0 Sell rating(s)
4 Hold rating(s)
16 Buy rating(s)
2 Strong Buy rating(s)
2.91

Medtronic has a net margin of 13.90% compared to DexCom's net margin of 12.90%. DexCom's return on equity of 30.05% beat Medtronic's return on equity.

Company Net Margins Return on Equity Return on Assets
Medtronic13.90% 14.54% 7.83%
DexCom 12.90%30.05%10.00%

Summary

DexCom beats Medtronic on 11 of the 16 factors compared between the two stocks.

Get Medtronic News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDT vs. The Competition

MetricMedtronicMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$114.83B$10.25B$5.54B$20.85B
Dividend Yield3.17%2.06%3.75%3.65%
P/E Ratio24.7611.7121.0126.34
Price / Sales3.4330.03433.8159.22
Price / Cash11.5522.3936.1622.29
Price / Book2.383.578.124.66
Net Income$4.66B$235.43M$3.25B$994.58M
7 Day Performance-0.43%-1.67%0.97%-0.29%
1 Month Performance4.62%2.91%7.36%4.91%
1 Year Performance10.37%-16.44%31.31%10.53%

Medtronic Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MDT
Medtronic
4.6379 of 5 stars
$89.63
+0.1%
$98.19
+9.5%
+10.2%$114.83B$33.54B24.7695,000Positive News
Analyst Forecast
Analyst Revision
DXCM
DexCom
4.7866 of 5 stars
$85.20
+2.2%
$98.50
+15.6%
-26.6%$33.39B$4.15B63.5410,300Positive News
Analyst Forecast
ISRG
Intuitive Surgical
4.7015 of 5 stars
$519.40
+1.4%
$592.86
+14.1%
+21.1%$186.16B$8.35B76.1615,638Positive News
Upcoming Earnings
Analyst Revision
ABT
Abbott Laboratories
4.988 of 5 stars
$132.55
+0.4%
$143.11
+8.0%
+15.3%$230.62B$42.34B17.19114,000Trending News
Earnings Report
Ex-Dividend
Analyst Forecast
JNJ
Johnson & Johnson
4.7823 of 5 stars
$156.57
-0.2%
$171.00
+9.2%
+4.1%$376.71B$89.33B17.42138,100Trending News
Earnings Report
Dividend Announcement
Analyst Forecast
Options Volume
Analyst Revision
NVST
Envista
3.7638 of 5 stars
$20.08
-0.6%
$20.23
+0.7%
+15.1%$3.41B$2.51B-3.0812,300News Coverage
Analyst Revision
SYK
Stryker
4.7787 of 5 stars
$392.29
+0.7%
$428.55
+9.2%
+16.3%$149.88B$22.60B53.0653,000Positive News
TMO
Thermo Fisher Scientific
4.9933 of 5 stars
$426.69
-1.9%
$600.30
+40.7%
-23.4%$161.07B$42.90B25.03125,000Trending News
Upcoming Earnings
Analyst Forecast
Analyst Revision
BSX
Boston Scientific
4.6219 of 5 stars
$104.88
+1.6%
$116.09
+10.7%
+35.1%$155.16B$16.75B76.5553,000Trending News
Upcoming Earnings
BDX
Becton, Dickinson and Company
4.7555 of 5 stars
$176.73
+0.4%
$219.22
+24.0%
-22.8%$50.65B$20.87B33.7374,000Analyst Revision
EW
Edwards Lifesciences
4.3727 of 5 stars
$78.66
+0.8%
$80.40
+2.2%
-12.7%$46.14B$5.44B11.2415,800Positive News
Upcoming Earnings
Analyst Forecast

Related Companies and Tools


This page (NYSE:MDT) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners